Characterization of an Interleukin-6- and Adrenocorticotropin-Dependent, Immune-to-Adrenal Pathway during Viral Infection
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
There has been longstanding interest in the capacity of the immune system to access immunomodulatory glucocorticoid responses without invoking upstream neuroendocrine secretagogues, including CRH and ACTH. Here, we investigate the role of CRH and ACTH in adrenal glucocorticoid responses to murine cytomegalovirus (MCMV). Mice infected with MCMV exhibit IL-6-dependent glucocorticoid responses that peak at 36 h post infection and protect against cytokine (TNFalpha)-mediated lethality. Acute administration of a CRH-antibody (Ab) completely eliminated ACTH responses to both low- and high-dose MCMV. However, corticosterone responses in CRH-Ab-treated animals remained apparent in mice infected with low-dose MCMV and were robust in mice infected with high-dose MCMV. CRH-knockout (KO) mice exhibited robust corticosterone responses to both MCMV doses, despite reduced baseline and MCMV-induced ACTH. Interestingly, robust corticosterone responses in CRH-Ab-treated and CRH-KO mice were associated with exaggerated IL-6 levels, and IL-6 and corticosterone concentrations in infected CRH-Ab-treated animals were significantly correlated. Neutralization of IL-6 responses in infected CRH-KO mice reduced corticosterone responses by approximately 70%. Finally, MCMV-infected mice deprived of ACTH by hypophysectomy failed to elicit glucocorticoid responses, despite elevated plasma IL-6 concentrations. Taken together, these results suggest that a greater than normal induction of IL-6 compensates for the absence of a normal CRH-dependent ACTH surge during viral infection. This enhanced IL-6 response, in turn, may mediate a direct immune-adrenal pathway that can become a predominant driving force for glucocorticoid induction in the absence of CRH. However, the presence of ACTH appears to serve as a necessary permissive factor, enabling direct cytokine actions on the adrenal gland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immune-neuro-endocrine interactions: facts and hypotheses.
BESEDOVSKY, H. O., & REY, A. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-1-64 · Cited by 1,564
Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297 · cited 6×
“• Immune-to-Adrenal Pathway in Viral Infection Endocrinology, August 2004, 145(8):3580–3589 3581”
BackgroundInfluentialThe Pathophysiologic Roles of Interleukin-6 in Human Disease
Papanicolaou, D. A., Wilder, R. L., Manolagas, S. C., & Chrousos, G. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-2-199801150-00009 · Cited by 1,146
McEwen, B. S., Biron, C. A., Brunson, K. W., Bulloch, K., Chambers, W. H., Dhabhar, F. S., Goldfarb, R. H., Kitson, R. P., Miller, A. H., Spencer, R. L., et al. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00012-4 · Cited by 837
Self-citationIntraadrenal interactions in the regulation of adrenocortical steroidogenesis.
Ehrhart-Bornstein, M., Hinson, J. P., Bornstein, S. R., Scherbaum, W. A., & Vinson, G. P. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0326 · Cited by 600
Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans.
Mastorakos, G., Chrousos, G. P., & Weber, J. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263159 · Cited by 591 · cited 1×
“In support of this notion, IL-6 production is increased in many clinical situations characterized by tissue injury and chronic inflammation (87), and long-term IL-6 administration in humans stimulates elevated levels of cortisol in the presence of low levels of ACTH (76, 88, 89).”
BackgroundCorticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need
Muglia, L., Jacobson, L., Dikkes, P., & Majzoub, J. A. (1995) · Nature · doi:10.1038/373427a0 · Cited by 524
Naitoh, Y., Fukata, J., Tominaga, T., Nakai, Y., Tamai, S., Mori, K., & Imura, H. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81305-6 · Cited by 421
Bethin, K. E., Vogt, S. K., & Muglia, L. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9317 · Cited by 381 · cited 8×
“Relevant to neuroendocrine pathways by which IL-6 may induce a glucocorticoid response, IL-6 receptors (IL-6Rs) have been detected in the brain (16, 17), pituitary (18, 19) Abbreviations: Ab, Antibody; AVP, arginine vasopressin; CV, coefficient of variation; HPA, hypothalamic-pituitary-adrenal; HSFM, hybridoma serum-f…”
BackgroundResultInfluentialBornstein, S. R., & Chrousos, G. P. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5631 · Cited by 354
Mastorakos, G., Weber, J. S., Magiakou, M. A., Gunn, H., & Chrousos, G. P. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962300 · Cited by 290 · cited 2×
“In support of this notion, IL-6 production is increased in many clinical situations characterized by tissue injury and chronic inflammation (87), and long-term IL-6 administration in humans stimulates elevated levels of cortisol in the presence of low levels of ACTH (76, 88, 89).”
BackgroundBeishuizen, A., Thijs, L. G., & Vermes, I. (2001) · Intensive Care Medicine · doi:10.1007/s001340101073 · Cited by 245
BERNARDINI, R., KAMILARIS, T. C., CALOGERO, A. E., JOHNSON, E. O., GOMEZ, M. T., GOLD, P. W., & CHROUSOS, G. P. (1990) · Endocrinology · doi:10.1210/endo-126-6-2876 · Cited by 232
Karalis, K., Muglia, L. J., Bae, D., Hilderbrand, H., & Majzoub, J. A. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00178-6 · Cited by 203
The Effect of Interleukin-6 on Pituitary Hormone Release in vivo and in vitro
Lyson, K., & McCann, S. M. (2008) · Neuroendocrinology · doi:10.1159/000125884 · Cited by 179
Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection
Ruzek, M. C., Pearce, B. D., Miller, A. H., & Biron, C. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3527 · Cited by 153
Self-citationInterleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man.
Späth-Schwalbe, E., Born, J., Schrezenmeier, H., Bornstein, S. R., Stromeyer, P., Drechsler, S., Fehm, H. L., & Porzsolt, F. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962296 · Cited by 145 · cited 1×
“In support of this notion, IL-6 production is increased in many clinical situations characterized by tissue injury and chronic inflammation (87), and long-term IL-6 administration in humans stimulates elevated levels of cortisol in the presence of low levels of ACTH (76, 88, 89).”
BackgroundTurnbull, A. V., Smith, G. W., Lee, S., Vale, W. W., Lee, K.-F., & Rivier, C. (1999) · Endocrinology · doi:10.1210/endo.140.2.6675 · Cited by 96
Interleukin-3 and interleukin-6 stimulate cortisol secretion from adult human adrenocortical cells
Weber, M. M., Michl, P., Auernhammer, C. J., & Engelhardt, D. (1997) · Endocrinology · doi:10.1210/endo.138.5.5239 · Cited by 74
Vasopressin: A potent autocrine/paracrine regulator of mammal adrenal functions.
Guillon, G., Grazzini, E., Andrez, M., Breton, C., Trueba, M., Gal, C. S.-L., Boccara, G., Derick, S., Chouinard, L., & Gallo-payet, N. (1998) · Endocrine Research · doi:10.3109/07435809809032672 · Cited by 55
Mechanisms of activation of the pituitary-adrenal axis by tissue injury in the rat.
Turnbull, A. V., Dow, R. C., Hopkins, S. J., White, A., Fink, G., & Rothwell, N. J. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90006-x · Cited by 49
Cited by
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
Sternberg, E. M. (2006) · Nature Reviews Immunology · doi:10.1038/nri1810 · Cited by 1,064
Russell, G., & Lightman, S. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0228-0 · Cited by 1,032
Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters
Del Giudice, M., & Gangestad, S. W. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.013 · Cited by 779
“IL-6 has an activating effect on the HPA axis and increases adrenal production of cortisol, thereby raising blood levels of cortisol in response to a stressor (see Marsland et al., 2017; Silverman et al., 2004; Zarkovic et al., 2008).”
Inflamed moods: A review of the interactions between inflammation and mood disorders
Rosenblat, J. D., Cha, D. S., Mansur, R. B., & McIntyre, R. S. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.01.013 · Cited by 609
Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection
Silverman, M. N., Pearce, B. D., Biron, C. A., & Miller, A. H. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.41 · Cited by 506
Self-citation
Metadata
- Authors
- Silverman, M. N., Miller, A. H., Biron, C. A., & Pearce, B. D.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2004-08-01
- Volume
- 145
- Issue
- 8
- Pages
- 3580-3589
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2029761100
- Cited by
- 76
- References
- 21
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.